143 related articles for article (PubMed ID: 24678813)
1. Experience with a gonadotrophin-releasing hormone agonist prior to myomectomy--comparison of twice- vs thrice-monthly doses and a control group.
Bassaw B; Mohammed N; Jaggat A; Singh-Bhola M; Ramkissoon A; Singh P; Jones K; Maharaj S; Ramsewak S
J Obstet Gynaecol; 2014 Jul; 34(5):415-9. PubMed ID: 24678813
[TBL] [Abstract][Full Text] [Related]
2. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
4. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate.
Chang WC; Chu LH; Huang PS; Huang SC; Sheu BC
J Minim Invasive Gynecol; 2015; 22(6):992-6. PubMed ID: 25958038
[TBL] [Abstract][Full Text] [Related]
6. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
8. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
Kitade M; Kumakiri J; Kobori H; Murakami K
Trials; 2024 May; 25(1):343. PubMed ID: 38790029
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
Lethaby A; Vollenhoven B; Sowter M
BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
[TBL] [Abstract][Full Text] [Related]
12. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
Nikolov A; Karag'ozov I
Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials.
Chen I; Motan T; Kiddoo D
J Minim Invasive Gynecol; 2011; 18(3):303-9. PubMed ID: 21545958
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
15. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
Farquhar C; Brown PM; Furness S
BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial.
Vercellini P; Trespìdi L; Zaina B; Vicentini S; Stellato G; Crosignani PG
Fertil Steril; 2003 Jun; 79(6):1390-5. PubMed ID: 12798887
[TBL] [Abstract][Full Text] [Related]
18. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
Hutchins FL
J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
[TBL] [Abstract][Full Text] [Related]
20. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
Khurana C; Taylor P; de Belder MA
Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
